Work

Table S3 from Results of an Open-label, Phase Ia/b Study of Pembrolizumab plus Olaratumab in Patients with Unresectable, Locally Advanced, or Metastatic Soft-Tissue Sarcoma

Year: 2023

Type: other

Abstract: Table S3: Pharmacokinetic parameters after a 60-minute IV infusion of olaratumab on Day 1 and Day 8 of Cycle 1 and Cycle 3 with pembrolizumab.

DOI: 10.1158/1078-0432.23710242.v1

Authors: Patrick Schöffski, Rastislav Bahleda, Andrew J. Wagner, Melissa A. Burgess, Niels Junker, Michael Chisamore, Patrick Peterson, Anna M. Szpurka, Matteo Ceccarelli, William D. Tap

Language: English

Topic: Sarcoma Diagnosis and Treatment

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: gold

OpenAlex ID: W4384827271

Cites:

Cited by:

Related to: 10